Multi-Purpose Solution
Showing 1 - 25 of >10,000
Refractive Ametropia Trial (BL-3100-NBR03 multi-purpose solution, renu® Advanced Formula multi-purpose solution)
Not yet recruiting
- Refractive Ametropia
- BL-3100-NBR03 multi-purpose solution
- renu® Advanced Formula multi-purpose solution
- (no location specified)
Sep 30, 2022
Refractive Errors Trial in Maitland (LID018869+RepleniSH, LID018869+Biotrue, Biofinity+RepleniSH)
Completed
- Refractive Errors
- LID018869+RepleniSH
- +3 more
-
Maitland, FloridaAlcon Investigator 6565
May 3, 2022
Myopia, Hyperopia Trial in United Kingdom, United States (Test solution, Control solution)
Completed
- Myopia
- Hyperopia
- Test solution
- Control solution
-
Sarasota, Florida
- +10 more
Mar 2, 2021
Healthy Contact Lens Wearers Trial in Fort Worth (Alcon MPDS, ReNu Fresh MPS)
Completed
- Healthy Contact Lens Wearers
- Alcon MPDS
- ReNu Fresh MPS
-
Fort Worth, TexasContact Alcon Call Center for Trial Locations
Sep 1, 2020
Refractive Errors Trial in Maitland, Bloomington, Memphis (Lehfilcon A contact lenses, Comfilcon A contact lenses, Multi-purpose
Completed
- Refractive Errors
- Lehfilcon A contact lenses
- +2 more
-
Maitland, Florida
- +2 more
Apr 22, 2021
Myopia Trial in Hsinchu (41% Silicone Hydrogel Soft Contact Lenses(SHSCL), ACUVUE® VITA™ (senofilcon C) Brand (Soft) Contact
Recruiting
- Myopia
- 41% Silicone Hydrogel Soft Contact Lenses(SHSCL)
- +3 more
-
Hsinchu, TaiwanApexLens Co., Ltd.
Feb 23, 2021
Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)
Completed
- Dry Eye Disease
- Reproxalap Ophthalmic Solution (0.25%)
- Placebo Comparator
-
Andover, MassachusettsAndover Eye Associates
Jan 24, 2023
Diabetic Ketoacidosis Trial in St Leonards, Redcliffe (Plasma-Lyte 148, 0.9% sodium chloride)
Not yet recruiting
- Diabetic Ketoacidosis
- Plasma-Lyte 148
- 0.9% sodium chloride
-
St Leonards, New South Wales, Australia
- +1 more
Feb 28, 2023
Elderly, Quality of Life, Physical Activity Trial (multi purpose activities)
Completed
- Elderly
- +2 more
- multi purpose activities
- (no location specified)
May 12, 2022
Potential Chemoprevention Drugs in Recurrent Hepatocellular
Recruiting
- Hepatocellular Carcinoma Recurrent
- Surgery
- No intervention for research purpose
-
Taichung, TaiwanChina Medical University Hospital, Department of Surgery
Aug 5, 2023
Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution
Recruiting
- Dry Eye Disease
- SY-201 Ophthalmic Solution 2.0%
- +3 more
-
Durham, North CarolinaLexitas
Jul 27, 2022
Healthy Subject Trial in Chengdu (GS3-007 oral liquid)
Not yet recruiting
- Healthy Subject
- GS3-007 oral liquid
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023
Complex Perianal Fistulas Trial in Changsha (Human TH-SC01 Cell Injection, Saline solution)
Not yet recruiting
- Complex Perianal Fistulas
- Human TH-SC01 Cell Injection
- Saline solution
-
Changsha, Hunan, ChinaXiangya Hospital Central University
Dec 28, 2022
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Rhegmatogenous Retinal Detachment - Macula Off Trial (ONL1204 Ophthalmic Solution, Sham treatment)
Not yet recruiting
- Rhegmatogenous Retinal Detachment - Macula Off
- ONL1204 Ophthalmic Solution
- Sham treatment
- (no location specified)
Feb 15, 2023
Dry Eye, Dry Eye Syndromes Trial in United States (Vehicle Opthalmic Solution, PL9643 Opthalmic Solution)
Recruiting
- Dry Eye
- Dry Eye Syndromes
- Vehicle Opthalmic Solution
- PL9643 Opthalmic Solution
-
Newport Beach, California
- +9 more
Jan 20, 2022
Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)
Completed
- Dry Eye
- Reproxalap Ophthalmic Solution (0.25%)
- Vehicle Ophthalmic Solution
-
Raynham, MassachusettsAndover Eye Associates (Raynham)
Aug 2, 2022
Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)
Not yet recruiting
- Papillary Renal Cell Carcinoma
- Pembrolizumab
- Placebo
- (no location specified)
Nov 24, 2023
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)
Recruiting
- Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
- Aficamten
- Placebo
-
Anchorage, Alaska
- +1 more
Oct 12, 2023
Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)
Recruiting
- Open Angle Glaucoma or Ocular Hypertension
- OPC-1085EL
- 0.005% Latanoprost
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Oct 14, 2022
Dry Eye Trial in United States (0.3% YP-P10 Ophthalmic Solution, 1% YP-P10 Ophthalmic Solution, YP-P10 Placebo Ophthalmic
Recruiting
- Dry Eye
- 0.3% YP-P10 Ophthalmic Solution
- +2 more
-
Phoenix, Arizona
- +6 more
Jul 15, 2022
Bleeding From Teeth, Bleeding Prophylaxis Trial in Worldwide (Tranexamic acid)
Recruiting
- Bleeding From Teeth
- Bleeding Prophylaxis
- Tranexamic acid
-
Loma Linda, California
- +18 more
Nov 21, 2023